Search Results 291-300 of 16791 for ESCITALOPRAM+OXALATE
Dasatinib is in a class of medications called tyrosine kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to ...
Serum immunoglobulin free light chain ≥ 10 mg/dL and abnormal serum immunoglobulin kappa lambda free light chain ratio. Subject must have received at least ...
About this study. The goal of this study is to evaluate and optimize our existing phosphorus MRI head coil and imaging sequence on healthy human volunteers.
ID-LV305 is a novel immunotherapy agent designed to target dendritic cells and stimulate the body's immune system to fight the spread and growth of cancer for ...
This medicine is also used alone to treat metastatic or locally advanced NSCLC in patients who have an abnormal EGFR gene (exon 20 insertion mutations), whose ...
The purpose of this study is to determine whether patients with ADPKD present with abnormal levels of fumarate that correlates with disease severity and this ...
About this study. The purposes of this study are to explore the association between female sex, reproductive history and clinical phenotypic variability in ...
However, the dose is usually not more than 300 milligrams (mg) of aliskiren, 10 mg of amlodipine, and 25 mg of hydrochlorothiazide once a day. Children—Use ...
Inclusion criteria: Patients post bilateral thyroid bed surgery (cancer, Graves' disease, multinodular goiter); Symptomatic hypocalcemia; Total calcium < 8 ...
About this study. This phase Ib/II trial studies the side effects and best way to give pembrolizumab with combination chemotherapy and radiation therapy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!